metformin zentiva õhukese polümeerikattega tablett
zentiva k.s. - metformiin - õhukese polümeerikattega tablett - 850mg 120tk; 850mg 100tk; 850mg 180tk; 850mg 60tk; 850mg 30tk; 850mg 200tk; 850mg 500tk
metformin zentiva õhukese polümeerikattega tablett
zentiva k.s. - metformiin - õhukese polümeerikattega tablett - 500mg 500tk; 500mg 50tk; 500mg 120tk; 500mg 300tk; 500mg 60tk; 500mg 400tk; 500mg 20tk; 500mg 180tk; 500mg 56tk; 500mg 80tk; 500mg 28tk
metformin zentiva õhukese polümeerikattega tablett
zentiva k.s. - metformiin - õhukese polümeerikattega tablett - 1000mg 56tk; 1000mg 30tk; 1000mg 100tk; 1000mg 120tk; 1000mg 60tk; 1000mg 180tk; 1000mg 90tk
segluromet
merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.
vildagliptin/ metformin elvim õhukese polümeerikattega tablett
sia elvim - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 60tk
vildagliptin/ metformin elvim õhukese polümeerikattega tablett
sia elvim - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 60tk
eucreas
novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
zomarist
novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.
metforal xr toimeainet prolongeeritult vabastav tablett
berlin-chemie ag - metformiin - toimeainet prolongeeritult vabastav tablett - 500mg 60tk; 500mg 15tk; 500mg 30tk
metforal xr toimeainet prolongeeritult vabastav tablett
berlin-chemie ag - metformiin - toimeainet prolongeeritult vabastav tablett - 1000mg 15tk; 1000mg 30tk; 1000mg 120tk; 1000mg 90tk; 1000mg 60tk